Thomas Wiesel

924 total citations
17 papers, 477 citations indexed

About

Thomas Wiesel is a scholar working on Molecular Biology, Endocrinology, Diabetes and Metabolism and Physiology. According to data from OpenAlex, Thomas Wiesel has authored 17 papers receiving a total of 477 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Molecular Biology, 4 papers in Endocrinology, Diabetes and Metabolism and 4 papers in Physiology. Recurrent topics in Thomas Wiesel's work include Coenzyme Q10 studies and effects (3 papers), Acute Myeloid Leukemia Research (2 papers) and Pain Mechanisms and Treatments (2 papers). Thomas Wiesel is often cited by papers focused on Coenzyme Q10 studies and effects (3 papers), Acute Myeloid Leukemia Research (2 papers) and Pain Mechanisms and Treatments (2 papers). Thomas Wiesel collaborates with scholars based in Germany, United States and Austria. Thomas Wiesel's co-authors include Werner Andler, Thomas Menke, Udo Kontny, Petra Niklowitz, Boris Zernikow, Gritta Janka, U. Gross‐Wieltsch, Karin Beutel, Udo zur Stadt and Hans‐Joachim Wagner and has published in prestigious journals such as Blood, The Journal of Clinical Endocrinology & Metabolism and Clinica Chimica Acta.

In The Last Decade

Thomas Wiesel

16 papers receiving 451 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Thomas Wiesel Germany	12	108	96	84	81	80	17	477
Xiaoying Liu China	13	57 0.5×	118 1.2×	51 0.6×	45 0.6×	64 0.8×	50	467
Paul Glynne United Kingdom	11	77 0.7×	70 0.7×	41 0.5×	58 0.7×	99 1.2×	21	475
Xiaoyan Xing China	13	43 0.4×	90 0.9×	62 0.7×	201 2.5×	102 1.3×	44	536
Gbenga Kazeem United Kingdom	13	183 1.7×	213 2.2×	135 1.6×	69 0.9×	95 1.2×	32	759
Dietmar Fuchs Austria	12	81 0.8×	85 0.9×	55 0.7×	22 0.3×	112 1.4×	18	491
Shaul G. Massry United States	12	26 0.2×	47 0.5×	67 0.8×	48 0.6×	116 1.4×	20	467
Sjoerd van Marle Netherlands	10	39 0.4×	94 1.0×	70 0.8×	88 1.1×	61 0.8×	19	481
Surasak Kantachuvesiri Thailand	16	27 0.3×	82 0.9×	88 1.0×	153 1.9×	254 3.2×	62	889
Vita Rovīte Latvia	13	50 0.5×	90 0.9×	48 0.6×	105 1.3×	180 2.3×	43	461
Thijs van Iersel Netherlands	9	43 0.4×	56 0.6×	188 2.2×	91 1.1×	54 0.7×	17	626

Countries citing papers authored by Thomas Wiesel

Since Specialization

Citations

This map shows the geographic impact of Thomas Wiesel's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Thomas Wiesel with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Thomas Wiesel more than expected).

Fields of papers citing papers by Thomas Wiesel

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Thomas Wiesel. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Thomas Wiesel. The network helps show where Thomas Wiesel may publish in the future.

Co-authorship network of co-authors of Thomas Wiesel

This figure shows the co-authorship network connecting the top 25 collaborators of Thomas Wiesel. A scholar is included among the top collaborators of Thomas Wiesel based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Thomas Wiesel. Thomas Wiesel is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

17 of 17 papers shown

Ahlmann, Martina, Birgit Fröhlich, Frieder Schaumburg, et al.. (2025). Utility and Pitfalls of β‐D‐Glucan for Diagnosis and Response Monitoring of Chronic Disseminated Candidiasis in Paediatric Cancer Patients. Mycoses. 68(8). e70102–e70102.

Fedders, Henning, Ameera Alsadeq, Christian Kellner, et al.. (2015). A Case of Concordant Twins with Infant ALL and Discordant Clinical Outcome – Part I: the genetic basis – identification of DSC2 as a gene with prognostic impact in infant MLL-rearranged ALL. Klinische Pädiatrie. 227(3). 1 indexed citations

Hirschfeld, Gerrit, Thomas Wiesel, T. Reinehr, et al.. (2015). Difficulties in screening for peripheral neuropathies in children with diabetes. Diabetic Medicine. 32(6). 786–789. 17 indexed citations

Fedders, Henning, Ameera Alsadeq, Britt‐Sabina Petersen, et al.. (2014). Analyses of a Pair of Concordant Twins with Infant ALL and Discordant Clinical Outcome Reveals Immunoescape As a Mechanism of Disease Persistence in MLL-Rearranged Leukemia. Blood. 124(21). 3791–3791. 1 indexed citations

Blankenburg, Markus, Nicole Kraemer, Gerrit Hirschfeld, et al.. (2012). Childhood diabetic neuropathy: functional impairment and non‐invasive screening assessment. Diabetic Medicine. 29(11). 1425–1432. 63 indexed citations

Schmid, Irene, Beate Häberle, Michael H. Albert, et al.. (2011). Sorafenib and cisplatin/doxorubicin (PLADO) in pediatric hepatocellular carcinoma. Pediatric Blood & Cancer. 58(4). 539–544. 52 indexed citations

Lehrnbecher, Thomas, Andishe Attarbaschi, Jorge Garbino, et al.. (2010). Posaconazole salvage treatment in paediatric patients: a multicentre survey. European Journal of Clinical Microbiology & Infectious Diseases. 29(8). 1043–1045. 62 indexed citations

Cernaianu, Grigore, et al.. (2010). Appendiceal carcinoid tumor with lymph node metastasis in a child: case report and review of the literature. Journal of Pediatric Surgery. 45(11). e1–e5. 22 indexed citations

Beutel, Karin, U. Gross‐Wieltsch, Thomas Wiesel, et al.. (2009). Infection of T lymphocytes in Epstein‐Barr virus‐associated hemophagocytic lymphohistiocytosis in children of non‐Asian origin. Pediatric Blood & Cancer. 53(2). 184–190. 60 indexed citations

10.

Menke, Thomas, Petra Niklowitz, Thomas Wiesel, & Werner Andler. (2008). Antioxidant level and redox status of coenzyme Q₁₀in the plasma and blood cells of children with diabetes mellitus type 1. Pediatric Diabetes. 9(6). 540–545. 25 indexed citations

11.

Niklowitz, Petra, Thomas Wiesel, Werner Andler, & Thomas Menke. (2007). Coenzyme Q10 concentration in the plasma of children suffering from acute lymphoblastic leukaemia before and during induction treatment. BioFactors. 29(2-3). 83–89. 4 indexed citations

12.

Karges, Beate, Rainer Muche, Ina Knerr, et al.. (2007). Levothyroxine in Euthyroid Autoimmune Thyroiditis and Type 1 Diabetes: A Randomized, Controlled Trial. The Journal of Clinical Endocrinology & Metabolism. 92(5). 1647–1652. 26 indexed citations

13.

Reinehr, Thomas, Reinhard W. Holl, Christian L. Roth, et al.. (2005). Insulin resistance in children and adolescents with type 1 diabetes mellitus: relation to obesity. Pediatric Diabetes. 6(1). 5–12. 43 indexed citations

14.

Zernikow, Boris, Erik Michel, Thomas Wiesel, et al.. (2004). Pain in pediatric oncology — children's and parents' perspectives. European Journal of Pain. 9(4). 395–395. 47 indexed citations

15.

Niklowitz, Petra, Thomas Menke, Thomas Wiesel, et al.. (2002). Coenzyme Q10 in plasma and erythrocytes: comparison of antioxidant levels in healthy probands after oral supplementation and in patients suffering from sickle cell anemia. Clinica Chimica Acta. 326(1-2). 155–161. 37 indexed citations

16.

Böhm, Η, et al.. (1956). On the evaluation of the anticonvulsive effect of different local anaesthetics.. PubMed. 108(3-4). 392–407. 6 indexed citations

17.

Böhm, Η, et al.. (1956). The difference in action on normal and convulsive cortical activity between a local anaesthetic (lidocaine) and barbiturates.. PubMed. 108(3-4). 408–19. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact